Document is current
Any future updates will be listed below
-
Authors
Lukacs, Nicholas W.
Hogan, Simon P.
- License Information
-
More Information
Article History
Accepted: 2 May 2025
First Online: 26 June 2025
Competing interests
: N.W.L. is the Chief Scientific Officer for Opsidio, which is developing antibodies to stem cell factor to target mast cells. S.P.H. receives research funding from Regeneron Pharmaceuticals.
